z-logo
open-access-imgOpen Access
Secukinumab Sustains Individual Clinical Responses Over Time in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial
Author(s) -
Paul Emery,
Iain B. McInnes,
P. Mease,
Michael Schiff,
Luminita Pricop,
S H Shen,
Z Wang,
Corine Gaillez
Publication year - 2018
Publication title -
skin the journal of cutaneous medicine
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.21
Subject(s) - secukinumab , psoriatic arthritis , medicine , dermatology , clinical trial , arthritis , psoriasis , physical therapy
not available. Disclosures: Study supported by Novartis. Copyright 2018 SKIN

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom